DelveInsight’s Menopause Market Insights and Forecast report provides the current and forecast of Menopause, upcoming innovations, individual market shares of the products, challenges, drivers, and barriers, market trends, and key competitors in the Menopause Market scenario.
Some facts of the Menopause Market Report:
- Global menopause market was valued at USD 15.53 billion in 2021, growing at a CAGR of 7.10% during the forecast period from 2022 to 2027 to reach USD 23.44 billion by 2027.
- The demand for products that help in management of menopause symptoms is witnessing a surge majorly due to the rising female aging population wherein age plays a prominent role in regulating menstrual cycle and the growing awareness regarding menopause among people. Thereby boosting the growth of the menopause market during the forecast period from 2022-2027.
- As per the figures quoted by the World Health Organization (WHO) in their Decade of Healthy Ageing (2020–2030) Report, the people in the age group of 60 years and above will account for a 34% higher share in the total population growing from one billion in 2019 to 1.4 billion in 2030.
- For instance, as per the facts provided by the United Nations Fund for Population Activities (2021), it has been estimated that by 2050, the older population in the APAC region would reach to 1.3 billion, out of which 53% of the total population share would be accounted for by the females.
- Some of the companies working in Menopause Market are ISIDEN, Novapharm, Arkopharma, Pileje, Thermamex, ÉLERTÉ Laboratories, Serelys Pharma, Besins Healthcare, Bayer, ITALFARMACO S.p.A, Pfizer Inc, Mylan NV, Teva Pharmaceuticals, TherapeuticsMD, Inc , Novo Nordisk, Novartis, Millicent Pharma, PADAGIS LLC, Vertical Pharmaceuticals LLC, Amgen and Others.
To know more facts about Menopause Market Research Report, Click Here: Menopause Market Assessment
Recent Developmental Activities in Menopause Market:
- In September 2021, Theramex received the regualatory approval for Bijuva® / Bijuve® (1mg estradiol / 100mg progesterone) across Europe and the UK. It is the first, and only, body-identical hormone therapy treatment (HRT) for estrogen deficiency symptoms in post-menopausal women with intact uterus and to be administered orally.
- In April 2019, Amgen and UCB (Euronext Brussels: UCB) received the regulatory approval from the U.S. Food and Drug Administration (FDA) for EVENITY™ (romosozumab-aqqg) which is intended for the treatment of osteoporosis in postmenopausal women at high risk for fracture.
Know more in detail about the recent developmental activities: Menopause Treatment Landscape
Menopause Companies:
ISIDEN, Novapharm, Arkopharma, Pileje, Thermamex, ÉLERTÉ Laboratories, Serelys Pharma, Besins Healthcare, Bayer, ITALFARMACO S.p.A, Pfizer Inc, Mylan NV, Teva Pharmaceuticals, TherapeuticsMD, Inc , Novo Nordisk, Novartis, Millicent Pharma, PADAGIS LLC, Vertical Pharmaceuticals LLC, Amgen
To get free access to Detailed information on Menopause Market Analysis, Click here: Menopause Companies and Product
Scope of the Menopause Market Report
- Study Period: 2019 – 2027
- Base Year: 2021
- Forecast Period: 2022 – 2027
- By Treatment Type (Hormonal Products, Non-Hormonal Products, And Dietary Supplements)
- By Distribution Channel (Hospitals, Retail, And Online Pharmacies)
- By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
- Delveinsight Analysis: Global menopause market was valued at USD 15.53 billion in 2021, growing at a CAGR of 7.10% during the forecast period from 2022 to 2027 to reach USD 23.44 billion by 2027.
Get free Access to the Menopause Sample Pages, Click here: Menopause Sample Report
Table of Contents:
1. Menopause Market Report Introduction
2. Menopause Market Executive Summary
3. Regulatory Analysis
4. Menopause Market Key Factors Analysis
5. Menopause Market Porter’s Five Forces Analysis
6. COVID-19 Impact Analysis on Menopause Market
7. Menopause Market Layout
8. Menopause Market Global Company Share Analysis – Key 3-5 Companies
9. Menopause Market Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/menopause-market